HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Jagan N. Rao Stephen C. Clark John H. Dark Permission Requests Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Rao, J. N. Articles by Dark, J. H. Search for Related Content PubMed PubMed Citation Articles by Rao, J. N. Articles by Dark, J. H. Related Collections Lung - basic science Lung - transplantation

Eur J Cardiothorac Surg 2003;23:497-502
© 2003 Elsevier Science NL

Improvements in lung compliance after pulmonary transplantation: correlation with interleukin 8 expression

^a Cardiothoracic Centre, Freeman Hospital, Newcastle upon Tyne NE7 7DN, UK
^b Comparative Biology Centre, University of Newcastle upon Tyne, Newcastle upon Tyne NE2 7HH, UK
^c Department of Surgery, University of Newcastle upon Tyne, Newcastle upon Tyne NE2 7HH. UK

Received 20 May 2002; received in revised form 18 September 2002; accepted 21 October 2002.

^* Corresponding author. Tel.: +44-191-284-3111; fax: +44-191-223-1152
e-mail: stephen.clark{at}nuth.northy.nhs.uk

Objective: Previous studies have suggested reductions in lung reperfusion injury when initial reperfusion is undertaken with the addition of pharmacological modulators. We investigated three pharmacological agents in a porcine model of left single lung transplantation to determine the effect on lung compliance and its relationship with the expression of the cytokine, interleukin-8 (IL-8). Methods: Donor lungs were preserved with modified Euro-Collins for a mean ischaemic time of 18.6 h. Pulmonary venous oxygenation, lung compliance and IL-8 expression were assessed over a 12-h period. Group A (n=5) was a control group with no interventions added, Group B was reperfused with the addition of intravenous inositol hexakisphosphate (InSP6) (0.02 mg/kg per min), Group C received the nitric oxide donor, 3-morpholinosydnonimine (SIN-1) (0.02 mg/kg per min) and Group D received intravenous Pentoxifylline (2 mg/kg per h). All interventions were administered at a pulmonary artery pressure of 20 mmHg. Results: Group D yielded the best oxygenation (P=0.0041) while Groups B and C were similar. All were superior to Group A (P<0.001). Lung compliance was significantly improved in Groups B, C and D compared to group A. In Group D, the greatest improvements in lung compliance were observed (P<0.0001). Similar observations were seen with regard to pulmonary vascular resistance. IL-8 expression was delayed until after 30 min of reperfusion in Group D, but was evident after 10 min in all the other groups. This correlates with the compliance and oxygenation data. Conclusions: The addition of InSP6 or SIN-1 at reperfusion significantly attenuates reperfusion injury compared with controls and improves lung compliance. The unique comparison with Pentoxifylline afforded by this study indicates that at the doses studied Pentoxifylline appears to be superior, correlating with a greater inhibition of IL-8 expression.

Key Words: Lung transplantation • Lung compliance • Interleukin-8 • Inositol hexakisphosphate • 3-Morpholinosydnonimine • Pentoxifylline